We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
INTEGRA BIOSCIENCES AG

Goldsite Diagnostics

Goldsite Diagnostics Inc. focuses on the development, manufacturing and sales of clinical laboratory devices and in-... read more Featured Products: More products

Download Mobile App




Portable POCT Immunofluorescence Analyzer Makes Testing Smarter, Faster and More Efficient

By LabMedica International staff writers
Posted on 12 May 2023

With existing POCT dry fluorescence methods it can be difficult to meet the accurate and sensitive detection requirements for clinical samples. More...

The new time-resolved fluorescence immunoassay (TRFIA) technology uses time-resolved techniques to measure fluorescence, combines long decay lifetime markers with time-resolved fluorescence, effectively eliminating non-specific fluorescence interference and greatly improving analytical sensitivity. Now, a new time-resolved immunofluorescence analyzer uses TRFIA technology to quantitatively measure the concentration of analytes in blood or other samples at the POC.

The FIA Go from Goldsite Diagnostics Inc. (Shenzhen, China) is a compact fluorescent immunoassay analyzer designed for POCT settings. The rapid, quantitative instrument is based on TRFIA technology for high precision and low interference. The high-performance portable analyzer with a wide-ranging parameter menu provides professionals with high-quality medical information and user-friendly handling.

Featuring easy operation and an Android operating system, the FIA Go analyzer supports multiple tests, including Vitamin D, Ferritin, Folic acid, hormones, thyroid panels, etc. With its one-step operation, the FIA Go analyzer provides fast and accurate results in minutes at the POC, making it suitable for delivering timely primary care at the physician's office. Other flexible application scenarios include clinical laboratories, clinical departments, emergency outpatient clinics, and ambulances.

Related Links:
Goldsite Diagnostics 


Platinum Member
Automated Coagulation Analyzer
Hemolumi H6
Gold Member
Quantitative POC Immunoassay Analyzer
EASY READER+
All-in-One Molecular System
AIO M160
HPV Test
Allplex HPV28 Detection
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Clinical Chemistry

view channel
Image: Researchers from the Department of Chemistry at Aarhus University have developed and tested a new technology that can identify and measure the concentration of pharmaceuticals in under 10 minutes. Today, this process takes up to an hour. That is critical waiting time for patients suffering from a stroke. (Image Credit: Aarhus University)

Point-of-Care Blood Test Could Speed Treatment Decisions in Acute Stroke

Minutes can shape treatment decisions in emergency stroke care, particularly when physicians need to know whether a patient is taking anticoagulants before administering clot-dissolving therapy.... Read more

Microbiology

view channel
Image: The clearance also broadens QIAstat-Dx\'s infectious disease testing menu in the U.S., which already includes panels for respiratory and gastrointestinal infections, as well as meningitis and encephalitis (Photo courtesy of Qiagen)

One-Hour Molecular Panel Expands Bloodstream Infection Testing for Gram-Negative Pathogens

Bloodstream infections can progress rapidly and lead to sepsis, organ failure, and death. In the United States, about 1.7 million adults develop sepsis each year, and at least 350,000 die during hospitalization... Read more

Industry

view channel
Image

Collaboration Combines AI Cognitive Assessment and RNA Blood Testing for Earlier Alzheimer’s Detection

Alzheimer’s disease is often identified only after substantial neurodegeneration, partly because current diagnostic pathways are fragmented and difficult to scale. As treatment shifts toward earlier intervention,... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.